Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 29, 2019 08:00 ET | Source: NuCana plc

NuCana to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

EDINBURGH, United Kingdom, Aug. 29, 2019 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will...
August 27, 2019 08:00 ET | Source: NuCana plc

NuCana to Participate in Citi’s 14th Annual Biotech Conference

EDINBURGH, United Kingdom, Aug. 27, 2019 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will host...
August 21, 2019 16:01 ET | Source: NuCana plc

NuCana Reports Second Quarter 2019 Financial Results and Provides Business Update

Numerous Clinical Data Announcements and Study Initiations Expected in 2019 Current Cash Balance Expected to Fund the Company Into 2021 EDINBURGH, United Kingdom, Aug. 21, 2019 (GLOBE NEWSWIRE)...
August 20, 2019 08:00 ET | Source: NuCana plc

Enrollment in the Independent Investigator-Sponsored Phase III Metastatic Pancreatic Study ACELARATE Has Been Suspended Following a Prespecified Futility Analysis

Imbalances in Prognostic Factors May Have Impacted Analysis Longer-term Follow-up by Study Sponsor is Ongoing to Determine Path Forward Encouraging Survival Trends Observed in Patient Sub-Groups...
July 17, 2019 07:00 ET | Source: NuCana plc

NuCana Announces First Patients Dosed in Phase I Study of NUC-7738

NUC-7738 is NuCana’s Third ProTide to Enter the Clinic Study Will Enroll Up To 61 Patients with Advanced Solid Tumors EDINBURGH, United Kingdom, July 17, 2019 (GLOBE NEWSWIRE) -- NuCana plc...
June 12, 2019 19:24 ET | Source: NuCana plc

NuCana Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Acelarin® for the Treatment of Biliary Tract Cancer

EDINBURGH, United Kingdom, June 12, 2019 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the...
May 30, 2019 16:01 ET | Source: NuCana plc

NuCana to Present at the Jefferies 2019 Healthcare Conference

EDINBURGH, United Kingdom, May 30, 2019 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will...
May 14, 2019 16:01 ET | Source: NuCana plc

NuCana Reports First Quarter 2019 Financial Results and Provides Business Update

Numerous Clinical Data Announcements and Study Initiations Expected in 2019 Current Cash Balance Expected to Fund the Company Into 2021 EDINBURGH, United Kingdom, May 14, 2019 (GLOBE NEWSWIRE) --...
April 02, 2019 08:00 ET | Source: NuCana plc

NuCana to Participate in the William Blair 3rd Late-Stage Therapeutics Conference

EDINBURGH, United Kingdom, April 02, 2019 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients...
March 07, 2019 16:01 ET | Source: NuCana plc

NuCana Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Business Update

Numerous Clinical Data Announcements and Study Initiations Expected in 2019 Current Cash Balance Expected to Fund the Company Into 2021 EDINBURGH, United Kingdom, March 07, 2019 (GLOBE NEWSWIRE)...